Evercore ISI Keeps Their Hold Rating on Hartford Financial (HIG)
In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Hartford Financial (HIG – Research Report), with ...
Evercore ISI Keeps Their Buy Rating on Dell Technologies (DELL)
Evercore ISI analyst Amit Daryanani maintained a Buy rating on Dell Technologies (DELL – Research Report) yesterday and set a price target of ...
Alibaba shares plunge as Trump order stirs China trade angst
Trump directed a US agency to limit Chinese spending on technology and other strategic US sectors. Read more at ...
Chinese ADRs Tumble on Trump Order, Led by 10% Plunge in Alibaba
Chinese stocks tumbled in US trading on Monday, led by the biggest selloff in Alibaba Group Holding Ltd. since 2022, after ...
Growth scare possibly unfolding ahead of Nvidia earnings, says Evercore ISI's Julian Emanuel
Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to talk the impact of tariffs, uncertainty, and ...
BioPharma Dive16h
Sanofi, Teva add to case for new bowel disease drug
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.